Publications
- What approach to ALK-positive NSCLC?2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Targeted treatment of bronchogenic carcinoma2020 | First Faculty of Medicine
- Clinical dilemma of lung cancer treatment with anti-PD-1 therapy (nivolumab) in the discovery of rheumatological problems with joint swelling - case report2020 | First Faculty of Medicine
- Atezolizumab ve druhé linii léčby nemalobuněčného plicního karcinomu2020 | First Faculty of Medicine
- Léčba checkpoint inhibitory anti-PD-1 u starších pacientů2019 | First Faculty of Medicine
- Pulmonary neuroendocrine tumors2016 | First Faculty of Medicine
- Targeted therapy in pulmonary medicine2016 | First Faculty of Medicine
- Neuroendocrine tumours2015 | First Faculty of Medicine
- Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer2023 | Third Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Klinická onkologie2023 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen
Loading network view...